121 related articles for article (PubMed ID: 6253429)
21. Mode of antibacterial action of cefprozil, a new cephalosporin, on Escherichia coli, Serratia marcescens and Morganella morganii.
Nishimoto K; Usui T; Miyake Y; Suginaka H
Hiroshima J Med Sci; 1991 Mar; 40(1):35-40. PubMed ID: 1864765
[TBL] [Abstract][Full Text] [Related]
22. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
Infection; 1983; 11(6):315-7. PubMed ID: 6321357
[TBL] [Abstract][Full Text] [Related]
23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
[TBL] [Abstract][Full Text] [Related]
24. In vitro studies of cefamandole.
Bodey GP; Weaver S
Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activity of 6- and 7-[2-(5-carboxyimidazole-4-carboxamido)phenylacetamido]-penicillins and cephalosporins.
Yasuda N; Iwagami H; Nakanishi E; Nakamiya T; Sasaki Y; Murata T
J Antibiot (Tokyo); 1983 Mar; 36(3):242-9. PubMed ID: 6339459
[TBL] [Abstract][Full Text] [Related]
26. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu HC; Chin NX; Labthavikul P
Infection; 1985; 13(3):146-55. PubMed ID: 3928497
[TBL] [Abstract][Full Text] [Related]
27. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.
Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A
J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023
[TBL] [Abstract][Full Text] [Related]
28. beta-Lactamase stability of some cephalosporins.
Coppi G
Ital J Biochem; 1984; 33(4):280A-285A. PubMed ID: 6439674
[No Abstract] [Full Text] [Related]
29. Effect of concentration on bactericidal activity of cefotaxime.
Shah PM; Troche G; Stille W
J Antimicrob Chemother; 1979 Jul; 5(4):419-22. PubMed ID: 114510
[No Abstract] [Full Text] [Related]
30. [Study of in vitro activity of 3 cephalosporins and their combination with 2 beta-lactamase inhibitors against 4 enterobacteria strains producing extended spectrum beta-lactamase].
Cattoen C; Duflos D; Bouillet L; Chatelain C; Mazars E
Pathol Biol (Paris); 1997 May; 45(5):425-9. PubMed ID: 9296097
[TBL] [Abstract][Full Text] [Related]
31. [Beta-lactamase activity and susceptibilities to antibiotics among some species of bacteria isolated from medical institution between December 1999 and February 2000].
Tanimoto A; Sadahisa K; Hayashibara T; Yamane Y; Adachi Y; Karino K; Yamauchi Y; Umeki F; Yasunaga M; Moriki S
Jpn J Antibiot; 2002 Sep; 55 Suppl A():79-85. PubMed ID: 12599531
[TBL] [Abstract][Full Text] [Related]
32. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
Ripa S; Prenna M
Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
[TBL] [Abstract][Full Text] [Related]
33. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
Then RL; Angehrn P
Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
[TBL] [Abstract][Full Text] [Related]
34. Detection of beta-lactamase activity with nitrocefin of multiple strains of various microbial genera.
Uri JV
Acta Microbiol Hung; 1985; 32(2):133-45. PubMed ID: 3933272
[TBL] [Abstract][Full Text] [Related]
35. Formaldehyde-resistance in Enterobacteriaceae and Pseudomonas aeruginosa: identification of resistance genes by DNA-hybridization.
Wollmann A; Kaulfers PM
Zentralbl Hyg Umweltmed; 1991 May; 191(5-6):449-56. PubMed ID: 1909132
[TBL] [Abstract][Full Text] [Related]
36. In-vitro studies on SQ 26,776, a new monobactam antibiotic.
Russell AD
J Antimicrob Chemother; 1981 Dec; 8 Suppl E():81-8. PubMed ID: 6799485
[No Abstract] [Full Text] [Related]
37. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Saito M; Azuma K; Nishino T; Tanino T
Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
[TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
Hanberger H; Nilsson LE; Maller R; Nilsson M
Scand J Infect Dis Suppl; 1990; 74():118-23. PubMed ID: 2129063
[TBL] [Abstract][Full Text] [Related]
39. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.
Nikaido H; Liu W; Rosenberg EY
Antimicrob Agents Chemother; 1990 Feb; 34(2):337-42. PubMed ID: 2109581
[TBL] [Abstract][Full Text] [Related]
40. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.
Legrand P; Fournier G; Buré A; Jarlier V; Nicolas MH; Decré D; Duval J; Philippon A
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):527-9. PubMed ID: 2504594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
